CN104491263A - Medicine capable of promoting blood circulation to remove blood stasis for esophagus cancer and preparation method of medicine - Google Patents
Medicine capable of promoting blood circulation to remove blood stasis for esophagus cancer and preparation method of medicine Download PDFInfo
- Publication number
- CN104491263A CN104491263A CN201410760909.7A CN201410760909A CN104491263A CN 104491263 A CN104491263 A CN 104491263A CN 201410760909 A CN201410760909 A CN 201410760909A CN 104491263 A CN104491263 A CN 104491263A
- Authority
- CN
- China
- Prior art keywords
- jin
- cross
- vinegar
- water
- mesh sieve
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 113
- 239000008280 blood Substances 0.000 title claims abstract description 68
- 210000004369 blood Anatomy 0.000 title claims abstract description 68
- 230000017531 blood circulation Effects 0.000 title claims abstract description 47
- 230000001737 promoting effect Effects 0.000 title claims abstract description 47
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 229940079593 drug Drugs 0.000 title claims description 35
- 208000000461 Esophageal Neoplasms Diseases 0.000 title abstract description 8
- 201000004101 esophageal cancer Diseases 0.000 title abstract description 8
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims abstract description 74
- 241000628997 Flos Species 0.000 claims abstract description 31
- 239000002994 raw material Substances 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 91
- 239000000052 vinegar Substances 0.000 claims description 71
- 235000021419 vinegar Nutrition 0.000 claims description 71
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims description 64
- 208000017897 Carcinoma of esophagus Diseases 0.000 claims description 59
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 59
- 201000005619 esophageal carcinoma Diseases 0.000 claims description 59
- 239000000843 powder Substances 0.000 claims description 41
- 241000252335 Acipenser Species 0.000 claims description 40
- 210000004712 air sac Anatomy 0.000 claims description 40
- 239000007788 liquid Substances 0.000 claims description 35
- 229910052742 iron Inorganic materials 0.000 claims description 29
- 238000009835 boiling Methods 0.000 claims description 27
- 239000009969 fructus bruceae Substances 0.000 claims description 17
- 240000007163 Livistona chinensis Species 0.000 claims description 14
- 239000000919 ceramic Substances 0.000 claims description 13
- 238000005202 decontamination Methods 0.000 claims description 13
- 230000003588 decontaminative effect Effects 0.000 claims description 13
- 239000012535 impurity Substances 0.000 claims description 13
- 229910052573 porcelain Inorganic materials 0.000 claims description 13
- 238000001704 evaporation Methods 0.000 claims description 12
- 230000008020 evaporation Effects 0.000 claims description 12
- 239000012467 final product Substances 0.000 claims description 10
- 235000012907 honey Nutrition 0.000 claims description 10
- 239000006187 pill Substances 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 229940126678 chinese medicines Drugs 0.000 claims description 6
- 239000012567 medical material Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 4
- 230000006837 decompression Effects 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 3
- 238000007670 refining Methods 0.000 claims description 3
- 238000011282 treatment Methods 0.000 abstract description 20
- 208000002193 Pain Diseases 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 13
- 235000013399 edible fruits Nutrition 0.000 abstract description 4
- 240000001829 Catharanthus roseus Species 0.000 abstract description 2
- 240000007643 Phytolacca americana Species 0.000 abstract description 2
- 235000009074 Phytolacca americana Nutrition 0.000 abstract description 2
- 244000097577 Rhus javanica Species 0.000 abstract description 2
- 235000010889 Rhus javanica Nutrition 0.000 abstract description 2
- 235000019270 ammonium chloride Nutrition 0.000 abstract description 2
- 235000005881 Calendula officinalis Nutrition 0.000 abstract 1
- 240000001432 Calendula officinalis Species 0.000 abstract 1
- 241000928504 Centipeda minima Species 0.000 abstract 1
- 240000000233 Melia azedarach Species 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 230000009182 swimming Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 21
- 206010028980 Neoplasm Diseases 0.000 description 18
- 235000013305 food Nutrition 0.000 description 16
- 210000004185 liver Anatomy 0.000 description 14
- 201000011510 cancer Diseases 0.000 description 13
- 230000006870 function Effects 0.000 description 13
- 208000019505 Deglutition disease Diseases 0.000 description 12
- 231100000614 poison Toxicity 0.000 description 12
- 239000002585 base Substances 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 210000003734 kidney Anatomy 0.000 description 11
- 201000010099 disease Diseases 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 238000001959 radiotherapy Methods 0.000 description 10
- 239000000126 substance Substances 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- 210000003238 esophagus Anatomy 0.000 description 8
- 238000010792 warming Methods 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 238000002512 chemotherapy Methods 0.000 description 6
- 238000007689 inspection Methods 0.000 description 6
- 230000002147 killing effect Effects 0.000 description 6
- 244000045947 parasite Species 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 201000009030 Carcinoma Diseases 0.000 description 5
- 206010008479 Chest Pain Diseases 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 230000007096 poisonous effect Effects 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 241000233866 Fungi Species 0.000 description 4
- 241000475481 Nebula Species 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- 229930013930 alkaloid Natural products 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 235000019615 sensations Nutrition 0.000 description 4
- 230000003068 static effect Effects 0.000 description 4
- 210000001562 sternum Anatomy 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010027336 Menstruation delayed Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000003211 malignant effect Effects 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 230000009747 swallowing Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 229960003048 vinblastine Drugs 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010013952 Dysphonia Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010014080 Ecchymosis Diseases 0.000 description 2
- 208000010473 Hoarseness Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- LPGWZGMPDKDHEP-HLTPFJCJSA-N Leurosine Chemical compound C([C@]1([C@@H]2O1)CC)N(CCC=1C3=CC=CC=C3NC=11)C[C@H]2C[C@]1(C(=O)OC)C1=CC([C@]23[C@H]([C@@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC LPGWZGMPDKDHEP-HLTPFJCJSA-N 0.000 description 2
- 206010027476 Metastases Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 208000029082 Pelvic Inflammatory Disease Diseases 0.000 description 2
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 2
- 208000004680 Rectal Fistula Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 241000220317 Rosa Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 244000223014 Syzygium aromaticum Species 0.000 description 2
- 206010043376 Tetanus Diseases 0.000 description 2
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 2
- 241000256856 Vespidae Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 206010002156 anal fistula Diseases 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- AUVZFRDLRJQTQF-KXEYLTKFSA-N lochnericine Chemical compound N1C2=CC=CC=C2[C@]2([C@H]34)C1=C(C(=O)OC)C[C@]3(CC)[C@H]1O[C@H]1CN4CC2 AUVZFRDLRJQTQF-KXEYLTKFSA-N 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000009401 metastasis Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 210000003800 pharynx Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000002243 precursor Chemical class 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 238000002271 resection Methods 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 2
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 2
- 229940032091 stigmasterol Drugs 0.000 description 2
- 235000016831 stigmasterol Nutrition 0.000 description 2
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- JXLYSJRDGCGARV-CFWMRBGOSA-N vinblastine Chemical compound C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-CFWMRBGOSA-N 0.000 description 2
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 2
- 229960004528 vincristine Drugs 0.000 description 2
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- XWMMEBCFHUKHEX-MRTCRTFGSA-N (+)-Taraxasterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C XWMMEBCFHUKHEX-MRTCRTFGSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- IOPDFSGGBHSXSV-ZPWDLUOLSA-N (3s,4ar,6ar,6ar,6br,8s,8as,12s,12as,14ar,14br)-4,4,6a,6b,8a,12,14b-heptamethyl-11-methylidene-1,2,3,4a,5,6,6a,7,8,9,10,12,12a,13,14,14a-hexadecahydropicene-3,8-diol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)[C@@H](O)C[C@]21C IOPDFSGGBHSXSV-ZPWDLUOLSA-N 0.000 description 1
- QMKPCZNFLUQTJZ-UHFFFAOYSA-N (4aR)-10c-Hydroxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen Natural products CC1CCC2(C)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C QMKPCZNFLUQTJZ-UHFFFAOYSA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
- 208000008710 Amebic Dysentery Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010001986 Amoebic dysentery Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 208000007026 Bronchial fistula Diseases 0.000 description 1
- LPZSTPCYWWRQFU-VILODJCFSA-N Bruceine A Chemical compound CC1=C(O)C(=O)C[C@]2(C)[C@@H]([C@@H](O)[C@@H]3O)[C@@]45CO[C@@]3(C(=O)OC)[C@@H]5[C@@H](OC(=O)CC(C)C)C(=O)O[C@@H]4C[C@H]21 LPZSTPCYWWRQFU-VILODJCFSA-N 0.000 description 1
- ZZZYHIMVKOHVIH-VILODJCFSA-N Brusatol Chemical compound CC1=C(O)C(=O)C[C@]2(C)[C@@H]([C@@H](O)[C@@H]3O)[C@@]45CO[C@@]3(C(=O)OC)[C@@H]5[C@@H](OC(=O)C=C(C)C)C(=O)O[C@@H]4C[C@H]21 ZZZYHIMVKOHVIH-VILODJCFSA-N 0.000 description 1
- ZZZYHIMVKOHVIH-UHFFFAOYSA-N Brusatol Natural products CC1=C(O)C(=O)CC2(C)C(C(O)C3O)C45COC3(C(=O)OC)C5C(OC(=O)C=C(C)C)C(=O)OC4CC21 ZZZYHIMVKOHVIH-UHFFFAOYSA-N 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 208000001387 Causalgia Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 241001517488 Clavus Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 208000023890 Complex Regional Pain Syndromes Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- GNGNFXDVNFGIIL-UHFFFAOYSA-N Ervincinine Natural products CCC12CC(=C3Nc4cc(OC)ccc4C35CCN(CC6OC16)C25)OC(=O)C GNGNFXDVNFGIIL-UHFFFAOYSA-N 0.000 description 1
- 208000007241 Experimental Diabetes Mellitus Diseases 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 208000016495 Horner Syndrome Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- JXLYSJRDGCGARV-PJXZDTQASA-N Leurosidine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-PJXZDTQASA-N 0.000 description 1
- LPGWZGMPDKDHEP-GKWAKPNHSA-N Leurosine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@]6(CC)O[C@@H]6[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C LPGWZGMPDKDHEP-GKWAKPNHSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- YKTXUUJZENEUGL-MKHRZCKRSA-N Lochnerinine Chemical compound N1C2=CC(OC)=CC=C2[C@]2([C@H]34)C1=C(C(=O)OC)C[C@]3(CC)C1OC1CN4CC2 YKTXUUJZENEUGL-MKHRZCKRSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 206010025391 Macroglossia Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- LELBFTMXCIIKKX-QVRQZEMUSA-N Mitragynine Chemical compound C1=CC(OC)=C2C(CCN3C[C@H]([C@H](C[C@H]33)\C(=C/OC)C(=O)OC)CC)=C3NC2=C1 LELBFTMXCIIKKX-QVRQZEMUSA-N 0.000 description 1
- 241000219926 Myrtaceae Species 0.000 description 1
- 208000000592 Nasal Polyps Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 244000021150 Orbignya martiana Species 0.000 description 1
- 235000014643 Orbignya martiana Nutrition 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 241000219505 Phytolaccaceae Species 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 240000003085 Quassia amara Species 0.000 description 1
- 235000009694 Quassia amara Nutrition 0.000 description 1
- 208000007660 Residual Neoplasm Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241001417494 Sciaenidae Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241001671204 Stemona Species 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241000775848 Syringa oblata Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- NAHTXVIXCMUDLF-DUJPAFNYSA-N Toosendanin Natural products O=C(O[C@H]1C(=O)[C@H]2[C@@](C)([C@H](O)C[C@H]3[C@@]4(C)[C@H](O)OC[C@@]23[C@@H](O)C[C@H]4OC(=O)C)[C@@]23[C@]1(C)[C@H](c1cocc1)C[C@H]2O3)C NAHTXVIXCMUDLF-DUJPAFNYSA-N 0.000 description 1
- 206010065787 Tracheal fistula Diseases 0.000 description 1
- 208000005864 Tracheoesophageal Fistula Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 102000004243 Tubulin Human genes 0.000 description 1
- 108090000704 Tubulin Proteins 0.000 description 1
- 241001593750 Turcica Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000863480 Vinca Species 0.000 description 1
- SASWULSUPROHRT-MCIGMTSASA-N Vindorosine Natural products CN([C@H]1[C@](O)([C@@H]2OC(C)=O)C(=O)OC)C3=CC=CC=C3[C@@]11CCN3CC=C[C@]2(CC)[C@@H]13 SASWULSUPROHRT-MCIGMTSASA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- JXLYSJRDGCGARV-KSNABSRWSA-N ac1l29ym Chemical compound C([C@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-KSNABSRWSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- -1 acetyl vindorosine Chemical compound 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- AGZMFTKKLPHOMT-DUJTVWLASA-N akuammicine Chemical compound C1CN([C@H]2C3)C\C(=C\C)[C@H]3C(C(=O)OC)=C3[C@@]12C1=CC=CC=C1N3 AGZMFTKKLPHOMT-DUJTVWLASA-N 0.000 description 1
- HKKCLUALMIXSKS-UHFFFAOYSA-N akuammicine Natural products CC=C/1CN2CCC34C2CC1C(=C3Nc5ccccc45)OC(=O)C HKKCLUALMIXSKS-UHFFFAOYSA-N 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- IOPDFSGGBHSXSV-UHFFFAOYSA-N arnidiol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(=C)CCC3(C)C(O)CC21C IOPDFSGGBHSXSV-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001612 cachectic effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 239000007766 cera flava Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 208000014439 complex regional pain syndrome type 2 Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- LPZSTPCYWWRQFU-UHFFFAOYSA-N dihydrobrusatol Natural products CC1=C(O)C(=O)CC2(C)C(C(O)C3O)C45COC3(C(=O)OC)C5C(OC(=O)CC(C)C)C(=O)OC4CC21 LPZSTPCYWWRQFU-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 229940084434 fungoid Drugs 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 239000010097 fuzheng yiliu Substances 0.000 description 1
- 238000002575 gastroscopy Methods 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- XTLWNMXYCHABQH-UHFFFAOYSA-N germanicol Natural products CC1(C)CCC2(C)CCC3(C)C(CCC4(C)C5(C)CCC(O)C(C)(C)C5CCC34C)C2=C1 XTLWNMXYCHABQH-UHFFFAOYSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 235000012171 hot beverage Nutrition 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- LIKBJVNGSGBSGK-UHFFFAOYSA-N iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Fe+3].[Fe+3] LIKBJVNGSGBSGK-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 235000014705 isoleucine Nutrition 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 208000022002 malignant neoplasm of cervical esophagus Diseases 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 208000016366 nasal cavity polyp Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- DWAFYCQODLXJNR-BNTLRKBRSA-L oxaliplatin Chemical compound O1C(=O)C(=O)O[Pt]11N[C@@H]2CCCC[C@H]2N1 DWAFYCQODLXJNR-BNTLRKBRSA-L 0.000 description 1
- 229960001756 oxaliplatin Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 235000008729 phenylalanine Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000013930 proline Nutrition 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- NGFFRJBGMSPDMS-UHFFFAOYSA-N psi-Taraxasterol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(C)=CCC3(C)CCC21C NGFFRJBGMSPDMS-UHFFFAOYSA-N 0.000 description 1
- 229940013788 quassia Drugs 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000008517 radix Trichosanthis Substances 0.000 description 1
- 210000002416 recurrent laryngeal nerve Anatomy 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 210000000331 sympathetic ganglia Anatomy 0.000 description 1
- HUTYZQWCTWWXND-NCTFTGAASA-N taraxasterol Natural products C[C@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(C)CCC1=C HUTYZQWCTWWXND-NCTFTGAASA-N 0.000 description 1
- GGGUGZHBAOMSFJ-GADYQYKKSA-N taraxerol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)[C@@H]1[C@]2(C)C2=CC[C@@]3(C)CCC(C)(C)C[C@H]3[C@]2(C)CC1 GGGUGZHBAOMSFJ-GADYQYKKSA-N 0.000 description 1
- HYTFUKZLSYXRDX-UHFFFAOYSA-N taraxerol Natural products CC1CCCC2C3(C)CCC4(C)C5CC(C)(C)CCC5(C)C=CC4(C)C3C(O)CC12C HYTFUKZLSYXRDX-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- NAHTXVIXCMUDLF-RFNFAWMESA-N toosendanin Chemical compound C=1([C@H]2[C@]3(C)[C@@H](OC(C)=O)C(=O)[C@H]4[C@@]([C@@]53O[C@@H]5C2)(C)[C@H](O)C[C@H]2[C@@]3(C)[C@H](O)OC[C@]24[C@@H](O)C[C@H]3OC(=O)C)C=COC=1 NAHTXVIXCMUDLF-RFNFAWMESA-N 0.000 description 1
- 239000008488 toosendanin Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 235000002374 tyrosine Nutrition 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 235000014393 valine Nutrition 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 208000016261 weight loss Diseases 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses a medicine capable of promoting blood circulation to remove blood stasis for an esophagus cancer and a preparation method of the medicine. The medicine is prepared from the following main raw materials in parts by weight: 6-10 parts of ruddle, 10-15 parts of flos caryophylli, 15-20 parts of szechwan chinaberry fruit, 9-18 parts of brucea javanica, 15-20 parts of nidus vespae, 10-20 parts of fructus livistonae, 15-30 parts of centipeda minima, 15-25 parts of pokeberry root, 2-5 parts of catharanthus roseus, 2-5 parts of sal ammoniac, 9-15 parts of hedyotis diffusa and 6-15 parts of drumfish swimming bladder. The medicine has the advantages of being relatively low in treatment cost, free of a wound, relatively short in curative time, and free of a side effect; and the pain of a patient is relieved.
Description
Technical field
The present invention relates to traditional Chinese medicine field, particularly relate to a kind of esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament and preparation method thereof.
Background technology
Esophageal carcinoma is common digestive tract tumor, and the whole world about has 300,000 people to die from esophageal carcinoma every year.Its M & M various countries are widely different.China is one of esophageal carcinoma hotspot in the world, and every annual is died of illness about 150,000 people.Man is more than female, and age of onset is many more than 40 years old.The Crowds Distribute of esophageal carcinoma and age, sex, occupation, race, region, living environment, dietary life habits, genetic predisposition etc. have certain relation.Through the disease that existing survey data display esophageal carcinoma may be caused by many factors.The cause of disease proposed is as follows: 1. chemical cause of disease nitrosamine.This compounds and precursor distribution very wide, can in vivo, outer formation, carcinogenecity is strong.2. biological agent fungus.In the grain of some district occurred frequently, in the upper digestive tract of esophageal cancer patients or in the esophageal carcinoma specimen of excision, all can isolate multiple fungus, wherein some fungus has carcinogenesis.Some fungus can impel the formation of nitrosamine and precursor thereof, more promotes the generation of cancerous protuberance.3. lack some trace element.4. be deficient in vitamin.Be deficient in vitamin A, vitamin B2, vitamin C and animal proteinum, fresh vegetables, fruit Deficiency of Intake, is a common feature of esophageal carcinoma district occurred frequently.5. the factors such as cigarette, wine, heat food, hot drink, oral cavity be unclean.Long-term drink ardent spirits, hobby smoking, food is really up to the mark, overheated, it is too fast to take food, and causes that chronic stimulation, inflammation, wound or oral cavity are unclean, dental caries etc. all may be relevant with the generation of esophageal carcinoma.6. esophageal carcinoma inheritance susceptible factor.Clinical manifestation: 1. early symptom is often not obvious, but discomfort sensation in various degree may be had when swallowing thick and stiff food, comprise ingest food choking feeling, after breastbone, burn sample, acupuncture sample or tractive friction sample pain.Food by slow, and has stagnation sense or foreign body sensation.Stalk is choked to stagnate to feel and alleviate disappearance after being swallowed water.Heavy time light during symptom, make slow progress.2. the typical symptom of middle and advanced stage esophageal carcinoma is Progressive symmetric erythrokeratodermia acataposis, before this food of difficult dry pharynx, is semiliquid diet then, and last water and saliva can not be swallowed.Often telling mucoid expectorant, is the saliva of hypopharynx and the secretions of esophagus.Patient becomes thin gradually, dewater, unable.Lasting chest pain or backache are expressed as symptom in late period, and cancer has been invaded esophagus and organized outward.When cancerous protuberance blocks caused inflammation edema transient remission, or after part cancerous protuberance comes off, obstruction can temporarily alleviate, and constant error thinks that sb.'s illness took a favorable turn.If cancerous protuberance invades recurrent laryngeal nerve, hoarseness can be there is; If compressing cervical sympathetic ganglia, Horner syndrome can be produced; If intrusion trachea-bronchial epithelial cell, esophagus, trachea or bronchial fistula can be formed, acutely choke when occurring swallowing water or food and cough, and respiratory system infection occurs.Finally there is cachectic states.If there is the Organ relative weight such as liver, brain, the states such as jaundice, seroperitoneum, stupor can be there is.
The treatment of esophageal carcinoma divides surgical intervention, radiotherapy, chemotherapy and Syndrome Types of TCM treatment etc.1. operative treatment.Operation is treatment esophageal carcinoma prefered method.If systemic conditions is good, have good cardio-pulmonary function deposit, without obvious metastasis sign person, can consider operative treatment.Generally larger with the chance of cervical part of esophagus cancer length < 3 centimetres, breast epimere cancer length < 4 centimetres, breast hypomere cancer length < 5 centimetres excision.But also have tumor body not too greatly but with major organs, can not the person of excision as the close adhesion such as aorta, trachea.The removability not quite all right person of entire patient is estimated to larger scale cancer, first can adopt preoperation radiotherapy, operate again after tumor body reduces.Surgical contraindication: 1. systemic conditions is poor, in cachexia.Or have the infull person of severe cardiac, lung or Liver and kidney function.2. pathological changes invades scope greatly, has obviously outer invading and signs of perforation, such as, has occurred hoarseness or existing esophago-tracheal fistula person.3. existing metastasis person.2. X-ray therapy.1. radiation and operative Combination Therapy, can increase Resection Rate, also can improve long term survival rate.After preoperation radiotherapy, having a rest, it is comparatively suitable within 3 ~ 4 weeks, to perform an operation again.Do metal marker to excising the incomplete residual tumor place of organizing in art, generally 3 ~ 6 weeks after surgery start postoperation radiotherapy.2. simple X-ray therapy, is used for cervical part of esophagus, breast epimere esophageal carcinoma, and usually difficulty is large in the operation of this kind of patient, and complication is many, and curative effect is unsatisfied with; Also can be used for having surgical contraindication and the pathological changes time not long, patient still can tolerate radiotherapy person.3. chemotherapy.The Comprehensive Treatment adopting chemotherapy to combine with operative treatment or combine with radiotherapy, Chinese medicine, sometimes can improve curative effect, or make esophageal cancer patients remission, showed prolonged survival.But make regular check on hemogram and hepatic and renal function, and note drug reaction.Syndrome Types of TCM is treated: differentiation of symptoms and signs for classification of syndrome is treated.A point card about esophageal carcinoma is had nothing in common with each other, and establishment of the therapeutic methods and Applying Medicine is also thereupon different.But method for the treatment of total not from depressed liver-energy dispersing and QI regulating, sending down the abnormal ascending QI blood stasis dispelling, blood circulation promoting and blood stasis dispelling, hard masses softening and resolving, the body resistance strengthening and constitution consolidating, promote the production of body fluid moisturize, heat-clearing and toxic substances removing, anticancer analgetic, warming YANG and invigorating QI etc.1. Qi-stagnation type.Main symptom: the performance of early esophageal cancer, without obvious dysphagia, during only for swallowing in sense esophagus gear choke, foreign body sensation or causalgia, the heavy tight sense of the gloomy discomfort of breast and back, time hidden time heavy dysphagia sense.X-ray inspection is mainly the pathological changes of early esophageal cancer.Pale tongue is dim, thin white fur of tongue, stringy and thready pulse.Method for the treatment of: depressed liver-energy dispersing and QI regulating, warming YANG and invigorating QI, Fuzheng Yiliu.2. obstruct type of choking.Main symptom: symptom is simple, slight stalk is choked or dysphagia.X-ray inspection belongs to early more, mid-term medullary, fungoid esophageal carcinoma.The dim green grass or young crops of body of the tongue, yellow fur is white, stringy and thready pulse.Method for the treatment of: anticancer dispersing, regulating QI and lowering the adverseness, warming YANG and strengthening body resistance.3. blood stasis type.Main symptom: symptom is except dysphagia, and based on chest pain, and pain has surely, or companion's halitosis etc.During x-ray inspection mostly is, late period medullary, ulcer type esophageal carcinoma.Body of the tongue purple is dim, and lingual surface has petechia or ecchymosis, and sublingual vein anger is opened, yellowish fur, deep and hesitant pulse and tight.Method for the treatment of: blood circulation promoting and blood stasis dispelling, warming YANG and invigorating QI, inducing menstruation to relieve menalgia.4. phlegm-damp type.Main symptom: dysphagia, accumulation and obstruction of sputum, breast pharynx dysphagia, diaphragm rib distension, adverse flow of turbid QI, the dim green grass or young crops of body of the tongue, macroglossia, has tooth to print in week, the white thick greasy many Tianjin of tongue, and pulse condition is sliding thin.X-ray inspection mostly is medullary in late period, constrictive type esophageal carcinoma.Method for the treatment of: warming YANG and invigorating QI, invigorating the spleen to clear away damp pathogen, sending down the abnormal ascending QI blood stasis dispelling.5. cloudy withered sun declines.Main symptom: stadium is late, acataposis is bordering on and blocks, vomiting and nausea QI rising in reverse order, emaciated physique, shortness of breath and fatigue, and dysphoria with smothery sensation lip is dry, and large dry stool is as excrement, and body of the tongue is dim deep red, slight of stature, few weary Tianjin of tongue or no fur, also has the black dry and person of splitting of yellow fur, thready and rapid pulse or heavy carefully unable.Method for the treatment of: nourishing YIN and invigorating YANG, benefiting QI and nourishing blood.
Application publication number CN 102475865 A(application number 201010573465.8) Chinese patent literature disclose a kind of Stemona tuber anticancer tablet for esophagus cancer, formulated by Radix Notoginseng, potassium iodide, Semen Persicae, the Radix Stemonae, Radix Glycyrrhizae, Lignum Aquilariae Resinatum, Borneolum Syntheticum, Sal Ammoniacus.Application publication number CN 103417610 A(application number 201310295133.1) Chinese patent literature disclose a kind of Chinese medicine for the treatment of esophageal carcinoma, it is made up of the raw material of following weight portion: Sal Ammoniacus 17-19 part, Borax 65-85 part, Borneolum Syntheticum 25-45 part, Galla Turcica (Galla Helepensis) 80-100 part, Radix Glycyrrhizae 15-35 part.Application publication number CN 103417810 A(application number 201310295242.3) Chinese patent literature disclose a kind of Chinese medicine for the treatment of esophageal carcinoma, it is made up of the raw material of following weight portion: Haematitum 25-35 part, Herba Agrimoniae 12-25 part, Radix Angelicae Sinensis 5-15 part, Rhizoma Dioscoreae 10-20 part, Radix Trichosanthis 10-20 part, Radix Asparagi 10-20 part, Radix Glycyrrhizae 10-20 part.
Operative treatment by cancer resection, but can bring postoperative dysfunction sometimes, and occurs some new symptoms.In addition, expenses of surgical treatment is high and there is certain risk.Reaction after radiotherapy and rear something lost phenomenon are also obvious.Chemotherapy also has obvious impact to digestive tract and hemopoietic system.Radiotherapy, chemotherapy can produce many side effect again, bring very large misery to patient.All kinds of symptoms that cancer causes, after taking Chinese medicine, often can obtain the improvement of certain hour.As cancer itself also takes a turn for the better because taking Chinese medicine, then symptom often can obviously be alleviated, even disappear.But the process for the treatment of by Chinese herbs cancer is very very long process, such tumor, when slowly disappearing, is brought a lot of slight illness to torment to patient undoubtedly, is also unfavorable for the treatment that patient is long-term.
Summary of the invention
For the deficiencies in the prior art, the object of this invention is to provide a kind of esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament and preparation method thereof.Medical expense of the present invention is lower, hurtless measure, healing time are shorter, have no side effect, alleviate patient suffering.
Technical scheme of the present invention is:
Esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament, takes off the primary raw material medicine stating weight proportion and is prepared from: Haematitum 6-10, Flos Caryophylli 10-15, Fructus Toosendan 15-20, Fructus Bruceae 9-18, Nidus Vespae 15-20, Chinese fanpalm seed 10-20, Herba Centipedae 15-30, Radix Phytolaccae 15-25, Herba Catharanthi Rosei 2-5, Sal Ammoniacus 2-5, Herba Hedyotidis Diffusae 9-15, Shishou Air Bladder pseudosciaenae seu Acipenser 6-15.
Esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament, preferred scheme is, takes off the primary raw material medicine stating weight proportion and is prepared from: Haematitum 7-9, Flos Caryophylli 11-13, Fructus Toosendan 17-19, Fructus Bruceae 12-15, Nidus Vespae 16-18, Chinese fanpalm seed 14-17, Herba Centipedae 20-25, Radix Phytolaccae 18-22, Herba Catharanthi Rosei 2.5-4, Sal Ammoniacus 2.5-4, Herba Hedyotidis Diffusae 11-13, Shishou Air Bladder pseudosciaenae seu Acipenser 8-13.
Esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament, the scheme be more preferably is, takes off the primary raw material medicine stating weight proportion and is prepared from: Haematitum 8, Flos Caryophylli 12, Fructus Toosendan 18, Fructus Bruceae 13, Nidus Vespae 17, Chinese fanpalm seed 15, Herba Centipedae 22, Radix Phytolaccae 20, Herba Catharanthi Rosei 3, Sal Ammoniacus 3, Herba Hedyotidis Diffusae 12, Shishou Air Bladder pseudosciaenae seu Acipenser 10.
Present invention also offers the preparation method above-mentioned esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament being made pharmaceutically acceptable decoction, pill, powder and thick paste agent.
The preparation method of described decoction is:
(1) wash Haematitum surface dirt with water, taking-up is dried, knock fritter, loads in crock, is placed in intense fire, burns to being popular in, and taking-up is placed on vinegar 2-5 two per jin in iron pan, and (preferred, taking-up is placed on vinegar 2.5-4 two per jin in iron pan; Be more preferably, take out and be placed on vinegar per jin 3 liang in iron pan), broken while hot, cool rear porphyrize, crosses 120-160 mesh sieve and (preferably, crosses 130-150 mesh sieve; Be more preferably, cross 140 mesh sieves);
(2) Sal Ammoniacus is picked decontamination, knock fritter, puts in boiling water and dissolves, and filters, removing residue, in impouring porcelain basin, with the evaporation of vinegar water proof, every 10 jin of Sal Ammoniacus vinegar 4-6 jin (preferred, every 10 jin of Sal Ammoniacus vinegar 4.5-5.5 jin; Be more preferably, every 10 jin of Sal Ammoniacus vinegar 5 jin), at any time the white that liquid level is separated out is floated frost and pull out, put in ceramic whiteware cylinder, dry, be ground into fine powder, cross 120-160 mesh sieve and (preferably, cross 130-150 mesh sieve; Be more preferably, cross 140 mesh sieves);
(3) Shishou Air Bladder pseudosciaenae seu Acipenser is cleaned, drain, explode to crisp with Oleum sesami, take out, be pressed into powder, cross 120-160 mesh sieve and (preferably, cross 130-150 mesh sieve; Be more preferably, cross 140 mesh sieves), put cold-bottling for subsequent use;
(4) by all the other the 7 taste crude drug removing impurity except Haematitum, Sal Ammoniacus, Shishou Air Bladder pseudosciaenae seu Acipenser, Flos Caryophylli and Herba Centipedae, clean, put into marmite, add water, amount of water is that doubly (preferred, amount of water is 6-7 times of 7 taste crude drug gross masses to the 5-8 of 7 taste crude drug gross masses; Be more preferably, amount of water is 6.5 times of 7 taste crude drug gross masses), first boil to boiling with big fire, rear turn of little fire decocts 1.1-2.1 hour, and (preferred, rear turn of little fire decocts 1.4-1.8 hour; Be more preferably, rear turn of little fire decocts 1.6 hours), leach medicinal liquid;
(5) Flos Caryophylli and Herba Centipedae being joined step (4) fills in the marmite of medicinal residues, adds water, and amount of water is that doubly (preferred, amount of water is 4-5 times of 9 taste medical material gross masses to the 3.5-6 of 9 taste medical material gross masses; Be more preferably, amount of water is 4.3 times of 9 taste crude drug gross masses), first boil to boiling with big fire, rear turn of little fire decocts 25-50 minute, and (preferred, rear turn of little fire decocts 30-45 minute; Be more preferably, rear turn of little fire decocts 38 minutes), leach medicinal liquid;
(6) step (4) and step (5) gained medicinal liquid are merged, then, step (1), step (2) and step (3) gained are added wherein, to obtain final product.
The preparation method of described pill is:
(1) wash Haematitum surface dirt with water, taking-up is dried, knock fritter, loads in crock, is placed in intense fire, burns to being popular in, and taking-up is placed on vinegar 2-5 two per jin in iron pan, and (preferred, taking-up is placed on vinegar 2.5-4 two per jin in iron pan; Be more preferably, take out and be placed on vinegar per jin 3 liang in iron pan), broken while hot, cool rear porphyrize, crosses 110-150 mesh sieve and (preferably, crosses 120-140 mesh sieve; Be more preferably, cross 130 mesh sieves);
(2) Sal Ammoniacus is picked decontamination, knock fritter, puts in boiling water and dissolves, and filters, removing residue, in impouring porcelain basin, with the evaporation of vinegar water proof, every 10 jin of Sal Ammoniacus vinegar 4-6 jin (preferred, every 10 jin of Sal Ammoniacus vinegar 4.5-5.5 jin; Be more preferably, every 10 jin of Sal Ammoniacus vinegar 5 jin), at any time the white that liquid level is separated out is floated frost and pull out, put in ceramic whiteware cylinder, dry, be ground into fine powder, cross 110-150 mesh sieve and (preferably, cross 120-140 mesh sieve; Be more preferably, cross 130 mesh sieves);
(3) Shishou Air Bladder pseudosciaenae seu Acipenser is cleaned, drain, explode to crisp with Oleum sesami, take out, be pressed into powder, cross 110-150 mesh sieve and (preferably, cross 120-140 mesh sieve; Be more preferably, cross 130 mesh sieves), put cold-bottling for subsequent use;
(4) all the other the 9 taste Chinese medicines except Haematitum, Sal Ammoniacus and Shishou Air Bladder pseudosciaenae seu Acipenser are removed impurity, porphyrize respectively, cross 110-150 mesh sieve and (preferably, cross 120-140 mesh sieve; Be more preferably, cross 130 mesh sieves);
(5) step (1), step (2), step (3) and step (4) gained fine powder are mixed, add water pill, heavy 0.25-0.7g(is preferred for every ball, the heavy 0.3-0.6g of every ball; Be more preferably, the heavy 0.5g of every ball), dry, to obtain final product.
The preparation method of described powder is:
(1) wash Haematitum surface dirt with water, taking-up is dried, knock fritter, loads in crock, is placed in intense fire, burns to being popular in, and taking-up is placed on vinegar 2-5 two per jin in iron pan, and (preferred, taking-up is placed on vinegar 2.5-4 two per jin in iron pan; Be more preferably, take out and be placed on vinegar per jin 3 liang in iron pan), broken while hot, cool rear porphyrize, crosses 130-170 mesh sieve and (preferably, crosses 140-160 mesh sieve; Be more preferably, cross 150 mesh sieves);
(2) Sal Ammoniacus is picked decontamination, knock fritter, puts in boiling water and dissolves, and filters, removing residue, in impouring porcelain basin, with the evaporation of vinegar water proof, every 10 jin of Sal Ammoniacus vinegar 4-6 jin (preferred, every 10 jin of Sal Ammoniacus vinegar 4.5-5.5 jin; Be more preferably, every 10 jin of Sal Ammoniacus vinegar 5 jin), at any time the white that liquid level is separated out is floated frost and pull out, put in ceramic whiteware cylinder, dry, be ground into fine powder, cross 130-170 mesh sieve and (preferably, cross 140-160 mesh sieve; Be more preferably, cross 150 mesh sieves);
(3) Shishou Air Bladder pseudosciaenae seu Acipenser is cleaned, drain, explode to crisp with Oleum sesami, take out, be pressed into powder, cross 130-170 mesh sieve and (preferably, cross 140-160 mesh sieve; Be more preferably, cross 150 mesh sieves), put cold-bottling for subsequent use;
(4) all the other the 9 taste Chinese medicines except Haematitum, Sal Ammoniacus and Shishou Air Bladder pseudosciaenae seu Acipenser are removed impurity, porphyrize respectively, cross 130-170 mesh sieve and (preferably, cross 140-160 mesh sieve; Be more preferably, cross 150 mesh sieves);
(5) step (1), step (2), step (3) and step (4) gained fine powder are mixed, sterile packaged, often wrap 4 grams.
The preparation method of described thick paste agent is:
(1) wash Haematitum surface dirt with water, taking-up is dried, knock fritter, loads in crock, is placed in intense fire, burns to being popular in, and taking-up is placed on vinegar 2-5 two per jin in iron pan, and (preferred, taking-up is placed on vinegar 2.5-4 two per jin in iron pan; Be more preferably, take out and be placed on vinegar per jin 3 liang in iron pan), broken while hot, cool rear porphyrize, crosses 120-160 mesh sieve and (preferably, crosses 130-150 mesh sieve; Be more preferably, cross 140 mesh sieves);
(2) Sal Ammoniacus is picked decontamination, knock fritter, puts in boiling water and dissolves, and filters, removing residue, in impouring porcelain basin, with the evaporation of vinegar water proof, every 10 jin of Sal Ammoniacus vinegar 4-6 jin (preferred, every 10 jin of Sal Ammoniacus vinegar 4.5-5.5 jin; Be more preferably, every 10 jin of Sal Ammoniacus vinegar 5 jin), at any time the white that liquid level is separated out is floated frost and pull out, put in ceramic whiteware cylinder, dry, be ground into fine powder, cross 120-160 mesh sieve and (preferably, cross 130-150 mesh sieve; Be more preferably, cross 140 mesh sieves);
(3) Shishou Air Bladder pseudosciaenae seu Acipenser is cleaned, drain, explode to crisp with Oleum sesami, take out, be pressed into powder, cross 120-160 mesh sieve and (preferably, cross 130-150 mesh sieve; Be more preferably, cross 140 mesh sieves), put cold-bottling for subsequent use;
(4) by all the other the 7 taste crude drug removing impurity except Haematitum, Sal Ammoniacus, Shishou Air Bladder pseudosciaenae seu Acipenser, Flos Caryophylli and Herba Centipedae, clean, put into marmite, add water, amount of water is that doubly (preferred, amount of water is 6-7.5 times of 7 taste crude drug gross masses to the 5.5-8.5 of 7 taste crude drug gross masses; Be more preferably, amount of water is 7 times of 7 taste crude drug gross masses), first boil to boiling with big fire, rear turn of little fire decocts 1.3-2.3 hour, and (preferred, rear turn of little fire decocts 1.6-2 hour; Be more preferably, rear turn of little fire decocts 1.8 hours), leach medicinal liquid;
(5) Flos Caryophylli and Herba Centipedae being joined step (4) fills in the marmite of medicinal residues, adds water, and amount of water is that doubly (preferred, amount of water is 4-5 times of 9 taste crude drug gross masses to the 3.5-6 of 9 taste crude drug gross masses; Be more preferably, amount of water is 4.3 times of 9 taste crude drug gross masses), first boil to boiling with big fire, rear turn of little fire decocts 30-50 minute, and (preferred, rear turn of little fire decocts 35-45 minute; Be more preferably, rear turn of little fire decocts 40 minutes), leach medicinal liquid;
(6) step (4) and step (5) gained medicinal liquid are merged, decompression, be concentrated into the thick paste that relative density is 1.32-1.42 and (preferably, be concentrated into the thick paste that relative density is 1.35-1.39; Be more preferably, be concentrated into the thick paste that relative density is 1.37), then add refined honey, it is preferred that every 100kg thick paste adds refined honey 125-150kg(, and every 100kg thick paste adds refined honey 135-145kg; Be more preferably, every 100kg thick paste adds refined honey 140kg, then step (1), step (2) and step (3) gained fine powder is added and mix well, micro-refining, foam removal, seals and get final product in dress aseptic bottle.
The pharmacology of the present invention's main raw material of Chinese medicine used is as follows:
Haematitum: having another name called palpus ball, red soil, fourth head Haematitum, blood teacher, purple Zhu, Haematitum, native Zhu, ferrum Zhu, ailhead Haematitum, nail Haematitum, red Haematitum, red stone, Haematitum, is the Ore of oxide-based mineral bloodstone.Main component: mainly containing iron sesquioxide, also containing a small amount of titanium, magnesium, aluminum, manganese, calcium, silicon and moisture.The property of medicine: bitter, sweet, flat.Return liver, stomach, pericardium channel.Function cures mainly: suppressing the hyperactive liver town is inverse, cooling blood for hemostasis.Control eructation vomiting, dysphagia and regurgitation, asthma, infantile convulsion, spit blood, epistaxis, hemorrhoidal hamorrhage, hemorrhoid complicated by anal fistula, bleeding not during menses.
Flos Caryophylli: another name: hundred knots, feelings visitor, Syringa oblata Lindl., sub-Flos Caryophylli, clove tree, dismemberent perfume, male Flos Caryophylli, Flos Caryophylli.Base is former: be the alabastrum of dicotyledon medicine plant clove of myrtaceae.The property of medicine: pungent, temperature.Return spleen, stomach, lung, kidney channel.Function cures mainly: warming middle-JIAO to send down the adverse QI, reinforcing the kidney and supporting YANG.For Deficiency and coldness of spleen and stomach, singultus is vomitted, lack of appetite and vomiting, trusted subordinate's cold type of pain, impotence due to deficiency of the kidney.
Fructus Toosendan: base is former: be the fruit of canella Fructus Toosendan.Chemical analysis: containing Toosendanin, alkaloid, kaempferol, resin, tannin.The property of medicine: bitter, cold, poisonous.Return liver, stomach, small intestine meridian.Function cures mainly: except damp and hot, clearing away liver-fire, pain relieving, parasite killing.Control epigastric pain with cold limbs due to adverseness of heat, hypochondriac pain, colic, abdominal pain due to worm stagnation.
Fructus Bruceae: base is former: be the fruit of quassia Fructus Bruceae.Chemical analysis: Fructus Bruceae claims bruceolic acid etc. containing alkaloid (brucamarine and yatanine etc.), glucoside (brucealin, brucealin etc.), phenolic constituent (brucenol etc.) and a kind of hydroxy carboxylic acid.The fatty oil of java brucea seed (Oleum Fructus Bruceae) 56.23%.In oil, non-saponifiable matter accounts for 1.36%, includes volatile oil a little; Saponified 92.47%, include oleic acid (same under accounting for the % of crude oil) 81.87%, linoleic acid 3.37%, stearic acid 2.65%, Palmic acid 6.62% etc.; Fusing point is the spun silk shape crystalline solid 4.59% of 152 DEG C in addition.Containing the bitter principle of similar guassin on various structures in seed: Brusatol, bruceine A, B, C, D, E, F, G, H etc.The property of medicine: bitter, cold, poisonous.Function cures mainly: heat clearing away, dampness, parasite killing, removing toxic substances.Control dysentery, chronic diarrhea, malaria, hemorrhoid, furunculosis, wart, clavus.
Nidus Vespae: base is former: be the nest of Vespidae insecticide yellow star long foot wasp or multiple nearly edge insecticide.Chemical analysis: Hornet nest is oily containing dew room, Cera Flava, resin, various saccharides, vitamin and inorganic salt etc.The property of medicine: micro-sweet, flat, mild toxicity.Return liver, stomach, kidney channel.Function cures mainly: the detumescence of wind-expelling pain-stopping, rose poison, killing parasites for relieving itching.Main air temperature arthralgia pain, wind carious pain, carbuncle malignant boil, scrofula, mouthpiece swell and ache, anal fistula, rubella pruritus, skin stubborn dermatitis.
Chinese fanpalm seed: another name seed of Livistona chinensis R.Br..Base is former: be the seed of babassu Semen livistonae chinensis.Chemical analysis: seed contains phenols, reducing sugar, tannin, triacylglycerol, aminoacid: lysine, serine, arginine, proline, tyrosine, valine, isoleucine, phenylalanine, sugar, vitamin C and ascorbic acid.The oil of shell and kernel is mainly containing oleic acid.The property of medicine: sweet, bitter, flat, mild toxicity.Function cures mainly: blood circulation promoting and blood stasis dispelling, hard masses softening and resolving.Main chronic hepatitis, lump in the abdomen.
Herba Centipedae: base is former: be the wounded in the battle herb of feverfew Myriogyne minuta.Chemical analysis: still contain stigmasterol, sitosterol, flavonoid, volatile oil, organic acid etc. containing multiple Triterpenoid, taraxerol, taraxasterol, arnidiol and another kind of three unknown terpinums in herb.The property of medicine: pungent, temperature." must book on Chinese herbal medicine be joined ": " enter meridian of Hand-TAI YIN edema caused by disorder of QI." function cures mainly: dispel the wind, cold expelling, victory is wet, removing nebula, stuffy nose relieving plug.Cure cold, asthma of cold-type, sore throat, pertussis, eruptive disease is suffered from abdominal pain, and amebic dysentery, malaria, infantile malnutrition with diarrhea, nasal sinusitis, nasal polyp, corneal nebula is puckery itches, ecthyma, scabies, traumatic injury.
Radix Phytolaccae: base is former: be the root of Phytolaccaceae plant pokeweed.Chemical analysis: containing phytolaccine, volume potassium nitrate, Saponin.The property of medicine: bitter, cold, poisonous.Enter spleen, urinary bladder channel.Function cures mainly: logical two just, removing water retention by purgation, eliminating stagnation.Harness the river swollen, distension, beriberi, sore throat, carbuncle, malignant boil.
Herba Catharanthi Rosei: base is former: be Apocynaceae periwinkle plant Herba Catharanthi Rosei, the herb of yellow Herba Catharanthi Rosei.Composition: plant containing indoles alkaloid more than 70 in Herba Catharanthi Rosei, comprise vinblastine, vincristine, lochnericine, lochnericine, remove acetyl vindorosine, vincaleucoblastine, Changchun Buddhist nun is fixed, lochnerinine etc.Root containing alkaloid, comprises that 9-methoxycorynantheidine., akuammicine, west, Changchun are fixed, lochnerivine, cavineine sulfate, sulphuric acid stay around western language alkali, and ammocalline, sulphuric acid group is around raw etc.Pharmacology: 1. antitumor action.The vinblastine that Herba Catharanthi Rosei contains, vincristine, leurosine, leurosidine have obvious antitumor action.2. Antitumor Mechanism.Herba Catharanthi Rosei antitumor action is directly relevant to the high-affinity of tubulin binding with medicine, suppress nucleic acid synthesis be it another mechanism.3. blood pressure lowering and vasodilative effect.No matter catharanthus roseus total alkaloids gavage, intramuscular injection or quiet note all have hypotensive effect to anesthetized dog, also has the effect of expansion coronary vasodilator.4. blood sugar lowering and effect for reducing blood fat.The water extract of this product leaf has normal or alloxan diabetes rabbit and dog and reduces blood glucose effect.The property of medicine: bitter, cold, poisonous.Function cures mainly: detoxicating and fighting cancer, heat clearing away suppressing the hyperactive liver.Cure mainly multiple cancerous protuberance, hypertension, carbuncle sore tumefacting virus, scald.
Sal Ammoniacus: base is former: be the crystal of halogenide class mineral Sal Ammoniacus.Chemical analysis: the main containing ammonium chloride of SALMIACUM.The property of medicine: the property of medicine: salty, bitter, pungent, temperature, poisonous.Return liver, spleen, stomach warp.Function cures mainly: removing food stagnancy softening the hard mass, drastically removing blood stasis and resolving static blood.Control lump in the abdomen Xuan tinea, dysphagia and regurgitation, phlegm retention, sore throat, long-pending dysentery, amenorrhea, corneal nebula, polyp, warty vegetation, furuncle, scrofula, carbuncle, malignant boil.
Herba Hedyotidis Diffusae: base is former: be the whole herb with root of Radix Rubiae kind of plant Herba Hedyotidis Diffusae.Chemical analysis: separate 1 alkane, stigmasterol, ursolic acid, oleanolic acid in herb, cupreol, cupreol-D-Glucose glycoside, P-coumaric acid etc.
The property of medicine: bitter, sweet, cold." Guangxi Chinese medicinal herbal ": " entering the heart, liver, spleen three warp " function cures mainly: heat clearing away, dampness removing, removing toxic substances.Control dyspnea and cough due to lung-heat, tonsillitis.Pharyngolaryngitis, appendicitis, dysentery, urinary tract infection, jaundice, hepatitis, pelvic inflammatory disease, adnexitis, carbuncle furuncle, venom, tumor.Also can be used for alimentary tract cancer.
Shishou Air Bladder pseudosciaenae seu Acipenser: base is former: be the Air Bladder pseudosciaenae seu Acipenser of Sciaenidae animal Carnis Pseudosciaenae or Carnis Pseudosciaenae.The property of medicine: sweet, flat.Return kidney, Liver Channel.Function cures mainly: the kidney invigorating and essence nourishing, nourishes muscle arteries and veins, hemostasis, dissipating blood stasis, detumescence.Control spermatorrhea of suffering from a deficiency of the kidney, puerperal puerperal tetanus, tetanus, spit blood, metrorrhagia, wound hemorrhage, hemorrhoid.
Esophageal carcinoma blood circulation promoting and blood stasis dispelling reagent combination provided by the invention is scientific and reasonable, products obtained therefrom taking convenience.In addition, excellent results of the present invention also shows:
1, do not perform the operation, not radiotherapy, not chemotherapy, not to be in hospital, hurtless measure, has no side effect, and patient easily accepts;
2, medical expense is lower, can alleviate the financial burden of patient;
3, healing time is shorter, alleviates patient suffering;
4, there is blood circulation promoting and blood stasis dispelling, detoxicating and fighting cancer, heat clearing away suppressing the hyperactive liver, reducing swelling and alleviating pain, removing food stagnancy softening the hard mass, drastically removing blood stasis and resolving static blood, the kidney invigorating and essence nourishing
Etc. effect, there is good curative effect for esophageal carcinoma;
5, by the diagnosis and prescription that the traditional Chinese medical science is traditional, strengthen antitumaous effect, strengthen immunologic function, prevent recurrence and transfer, life quality and the survival rate of patient can be significantly improved.
Detailed description of the invention
Describe technical scheme of the present invention in detail below in conjunction with embodiment and experimental example, but protection domain is not limited thereto.
embodiment 1esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament, the primary raw material medicine getting following weight parts is prepared from (every part is 25g): Haematitum 6 parts, Flos Caryophylli 10 parts, Fructus Toosendan 15 parts, Fructus Bruceae 9 parts, Nidus Vespae 15 parts, Chinese fanpalm seed 10 parts, Herba Centipedae 15 parts, Radix Phytolaccae 15 parts, Herba Catharanthi Rosei 2 parts, Sal Ammoniacus 2 parts, Herba Hedyotidis Diffusae 9 parts, 6 parts, Shishou Air Bladder pseudosciaenae seu Acipenser.
The preparation method of above-mentioned esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament decoction is:
(1) wash Haematitum surface dirt with water, taking-up is dried, knock fritter, loads in crock, is placed in intense fire, burns to being popular in, and takes out and is placed on vinegar per jin 2 liang in iron pan, broken while hot, and cool rear porphyrize crosses 120 mesh sieves;
(2) Sal Ammoniacus is picked decontamination, knock fritter, puts in boiling water and dissolves, and filters, removing residue, in impouring porcelain basin, with the evaporation of vinegar water proof, every 10 jin of Sal Ammoniacus vinegar 4 jin, float frost by the white that liquid level is separated out at any time and pull out, put in ceramic whiteware cylinder, dry, be ground into fine powder, cross 120 mesh sieves;
(3) Shishou Air Bladder pseudosciaenae seu Acipenser is cleaned, drain, explode to crisp with Oleum sesami, take out, be pressed into powder, cross 120 mesh sieves, put cold-bottling for subsequent use;
(4) by all the other the 7 taste crude drug removing impurity except Haematitum, Sal Ammoniacus, Shishou Air Bladder pseudosciaenae seu Acipenser, Flos Caryophylli and Herba Centipedae, clean, put into marmite, add water, amount of water is 5 times of 7 taste crude drug gross masses, first boils to boiling with big fire, rear turn of little fire decocts 1.1 hours, leaches medicinal liquid;
(5) Flos Caryophylli and Herba Centipedae being joined step (4) fills in the marmite of medicinal residues, adds water, and amount of water is 3.5 times of 9 taste medical material gross masses, first boils to boiling with big fire, and rear turn of little fire decocts 25 minutes, leaches medicinal liquid;
(6) step (4) and step (5) gained medicinal liquid are merged, then, step (1), step (2) and step (3) gained are added wherein, to obtain final product.
Esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament decoction instructions of taking of the present invention: every day twice, each 250mL(is warm).
embodiment 2esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament, the primary raw material medicine getting following weight parts is prepared from (every part is 25g): Haematitum 6-10 part, Flos Caryophylli 15 parts, Fructus Toosendan 20 parts, Fructus Bruceae 18 parts, Nidus Vespae 20 parts, Chinese fanpalm seed 20 parts, Herba Centipedae 30 parts, Radix Phytolaccae 25 parts, Herba Catharanthi Rosei 5 parts, Sal Ammoniacus 5 parts, Herba Hedyotidis Diffusae 15 parts, 15 parts, Shishou Air Bladder pseudosciaenae seu Acipenser.
The preparation method of above-mentioned esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament pill is:
(1) wash Haematitum surface dirt with water, taking-up is dried, knock fritter, loads in crock, is placed in intense fire, burns to being popular in, and takes out and is placed on vinegar per jin 3 liang in iron pan, broken while hot, and cool rear porphyrize crosses 130 mesh sieves;
(2) Sal Ammoniacus is picked decontamination, knock fritter, puts in boiling water and dissolves, and filters, removing residue, in impouring porcelain basin, with the evaporation of vinegar water proof, every 10 jin of Sal Ammoniacus vinegar 5 jin, float frost by the white that liquid level is separated out at any time and pull out, put in ceramic whiteware cylinder, dry, be ground into fine powder, 130 mesh sieves;
(3) Shishou Air Bladder pseudosciaenae seu Acipenser is cleaned, drain, explode to crisp with Oleum sesami, take out, be pressed into powder, cross 130 mesh sieves, put cold-bottling for subsequent use;
(4) all the other the 9 taste Chinese medicines except Haematitum, Sal Ammoniacus and Shishou Air Bladder pseudosciaenae seu Acipenser are removed impurity, porphyrize respectively, crosses 130 mesh sieves;
(5) step (1), step (2), step (3) and step (4) gained fine powder are mixed, add water pill, the heavy 0.5g of every ball, dry, to obtain final product.
model case one:king XX, female, 60 years old.Main suit: dysphagia companion gastral cavilty portion pain twinge 6 months.History of present illness: before 6 months, patient occurs dysphagia without obvious inducement, and diseases caused by retention of fluid is feasible, under paddy food difficulty, be hard and dry hard as sheep dung, skin is uninteresting, chokes with sobs.Body of the tongue purple is dim, and lingual surface has ecchymosis, yellow fur, white thick greasy, and pulse condition is carefully puckery.Be diagnosed as esophageal carcinoma.Carry out 1 course for the treatment of (23 times) radiotherapy afterwards in hospital, only can enter plastic flow food, weight loss more than 10 jin when leaving hospital, and in a wheat harvesting period after leaving hospital, the difficulty that repeatedly occurs dripping enters the phenomenon of esophagus irritation, always by transfusion maintenance.Take the present embodiment gained esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament pill, every day three times, each 10 balls.Take two weeks and can eat half bowl of rice, pain relief.Take and can eat half block steamed bun in 1 month.After taking medicine 3 months, health and ordinary person are as good as.
embodiment 3esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament, the primary raw material medicine getting following weight parts is prepared from (every part is 25g): Haematitum 7 parts, Flos Caryophylli 11 parts, Fructus Toosendan 17 parts, Fructus Bruceae 12 parts, Nidus Vespae 16 parts, Chinese fanpalm seed 14 parts, Herba Centipedae 20 parts, Radix Phytolaccae 18 parts, Herba Catharanthi Rosei 2.5 parts, Sal Ammoniacus 2.5 parts, Herba Hedyotidis Diffusae 11 parts, 8 parts, Shishou Air Bladder pseudosciaenae seu Acipenser.
The preparation method of above-mentioned esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament powder is:
(1) wash Haematitum surface dirt with water, taking-up is dried, knock fritter, loads in crock, is placed in intense fire, burns to being popular in, and takes out and is placed on vinegar per jin 3 liang in iron pan, broken while hot, and cool rear porphyrize crosses 150 mesh sieves;
(2) Sal Ammoniacus is picked decontamination, knock fritter, puts in boiling water and dissolves, and filters, removing residue, in impouring porcelain basin, with the evaporation of vinegar water proof, every 10 jin of Sal Ammoniacus vinegar 5 jin, float frost by the white that liquid level is separated out at any time and pull out, put in ceramic whiteware cylinder, dry, be ground into fine powder, cross 150 mesh sieves;
(3) Shishou Air Bladder pseudosciaenae seu Acipenser is cleaned, drain, explode to crisp with Oleum sesami, take out, be pressed into powder, cross 150 mesh sieves, put cold-bottling for subsequent use;
(4) all the other the 9 taste Chinese medicines except Haematitum, Sal Ammoniacus and Shishou Air Bladder pseudosciaenae seu Acipenser are removed impurity, porphyrize respectively, crosses 150 mesh sieves;
(5) step (1), step (2), step (3) and step (4) gained fine powder are mixed, sterile packaged, often wrap 4 grams.
model case two:normal XX, man, 55 years old.Main suit: more than Progressive symmetric erythrokeratodermia dysphagia March.History of present illness: patient was begun to feel and slightly to be choked with sobs sense after feed before March, because of symptom slightly and intermittently occur, therefore to treat.Rear symptom comparatively before obviously increase the weight of, occurrence number also increases, and becomes thin, and does not give Drug therapy, and symptom also has no improvement.Enter general food also to send out and choke, burn feeling after companion's breastbone, but enter semi-fluid sense of food and feel not obvious, be diagnosed as esophageal carcinoma.Take the present embodiment gained esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament powder, every day twice, each 4 grams, warm boiled water.Take 10 days, after breastbone, burn feeling alleviates.After taking 1 month, after breastbone, burn feeling disappears, and has a meal occasionally to have to send out and chokes.Continue to take two months, disease disappears, and diet is unimpeded, without uncomfortable.Follow up a case by regular visits to and do not recur so far.
embodiment 4esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament, the primary raw material medicine getting following weight parts is prepared from (every part is 25g): Haematitum 9 parts, Flos Caryophylli 13 parts, Fructus Toosendan 19 parts, Fructus Bruceae 15 parts, Nidus Vespae 18 parts, Chinese fanpalm seed 17 parts, Herba Centipedae 25 parts, Radix Phytolaccae 22 parts, Herba Catharanthi Rosei 4 parts, Sal Ammoniacus 4 parts, Herba Hedyotidis Diffusae 13 parts, 13 parts, Shishou Air Bladder pseudosciaenae seu Acipenser.
The preparation method of above-mentioned esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament thick paste agent is:
(1) wash Haematitum surface dirt with water, taking-up is dried, knock fritter, loads in crock, is placed in intense fire, burns to being popular in, and takes out and is placed on vinegar per jin 3 liang in iron pan, broken while hot, and cool rear porphyrize crosses 140 mesh sieves;
(2) Sal Ammoniacus is picked decontamination, knock fritter, puts in boiling water and dissolves, and filters, removing residue, in impouring porcelain basin, with the evaporation of vinegar water proof, every 10 jin of Sal Ammoniacus vinegar 5 jin, float frost by the white that liquid level is separated out at any time and pull out, put in ceramic whiteware cylinder, dry, be ground into fine powder, cross 140 mesh sieves;
(3) Shishou Air Bladder pseudosciaenae seu Acipenser is cleaned, drain, explode to crisp with Oleum sesami, take out, be pressed into powder, cross 140 mesh sieves, put cold-bottling for subsequent use;
(4) by all the other the 7 taste crude drug removing impurity except Haematitum, Sal Ammoniacus, Shishou Air Bladder pseudosciaenae seu Acipenser, Flos Caryophylli and Herba Centipedae, clean, put into marmite, add water, amount of water is 7 times of 7 taste crude drug gross masses, first boils to boiling with big fire, rear turn of little fire decocts 1.8 hours, leaches medicinal liquid;
(5) Flos Caryophylli and Herba Centipedae being joined step (4) fills in the marmite of medicinal residues, adds water, and amount of water is 4.3 times of 9 taste crude drug gross masses, first boils to boiling with big fire, and rear turn of little fire decocts 40 minutes, leaches medicinal liquid;
(6) step (4) and step (5) gained medicinal liquid are merged, decompression, be concentrated into the thick paste that relative density is 1.37, then refined honey is added, every 100kg thick paste adds refined honey 140kg, then step (1), step (2) and step (3) gained fine powder is added and mix well, micro-refining, foam removal, seals and get final product in dress aseptic bottle.
model case three:grandson XX, man, 52 years old.Main suit's dysphagia, based on chest pain.Health is fine usually, and flu all seldom has, but nearly two months have had a hunch that thing is stuck on esophagus, sometimes inadvertently swallow saliva, also can feel chest pain.Hospital diagnosis is gone to be esophageal carcinoma.Take the agent of the present embodiment gained esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament thick paste, every day three times, each 20 grams.Take two weeks, chest pain symptom alleviates.Continue to take 2 months, all diseases disappear, and go to hospital to do every inspection normal.
embodiment 5esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament, the primary raw material medicine getting following weight parts is prepared from (every part is 25g): Haematitum 8 parts, Flos Caryophylli 12 parts, Fructus Toosendan 18 parts, Fructus Bruceae 13 parts, Nidus Vespae 17 parts, Chinese fanpalm seed 15 parts, Herba Centipedae 22 parts, Radix Phytolaccae 20 parts, Herba Catharanthi Rosei 3 parts, Sal Ammoniacus 3 parts, Herba Hedyotidis Diffusae 12 parts, 10 parts, Shishou Air Bladder pseudosciaenae seu Acipenser.
The preparation method of above-mentioned esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament decoction is:
(1) wash Haematitum surface dirt with water, taking-up is dried, knock fritter, loads in crock, is placed in intense fire, burns to being popular in, and takes out and is placed on vinegar per jin 3 liang in iron pan, broken while hot, and cool rear porphyrize crosses 140 mesh sieves;
(2) Sal Ammoniacus is picked decontamination, knock fritter, puts in boiling water and dissolves, and filters, removing residue, in impouring porcelain basin, with the evaporation of vinegar water proof, every 10 jin of Sal Ammoniacus vinegar 5 jin, float frost by the white that liquid level is separated out at any time and pull out, put in ceramic whiteware cylinder, dry, be ground into fine powder, cross 140 mesh sieves;
(3) Shishou Air Bladder pseudosciaenae seu Acipenser is cleaned, drain, explode to crisp with Oleum sesami, take out, be pressed into powder, cross 140 mesh sieves, put cold-bottling for subsequent use;
(4) by all the other the 7 taste crude drug removing impurity except Haematitum, Sal Ammoniacus, Shishou Air Bladder pseudosciaenae seu Acipenser, Flos Caryophylli and Herba Centipedae, clean, put into marmite, add water, amount of water is 6.5 times of 7 taste crude drug gross masses, first boils to boiling with big fire, rear turn of little fire decocts 1.6 hours, leaches medicinal liquid;
(5) Flos Caryophylli and Herba Centipedae being joined step (4) fills in the marmite of medicinal residues, adds water, and amount of water is 4.3 times of 9 taste medical material gross masses, first boils to boiling with big fire, and rear turn of little fire decocts 38 minutes, leaches medicinal liquid;
(6) step (4) and step (5) gained medicinal liquid are merged, then, step (1), step (2) and step (3) gained are added wherein, to obtain final product.
test example 1the clinical practice of embodiment 5 esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament decoction: in June ,-2012 in April, 2010,232 routine esophageal cancer patients are screened in 8 hospitals, wherein male 132 example, women 100 example, oldest 74 years old, minimum 39 years old of age, 55 years old mean age, the course of disease 2 months-8 months, average 4 months.Be divided into two groups at random, experimental group and matched group (often organizing 116 people).Experimental group is male 66 example wherein, women 50 example, oldest 74 years old, minimum 39 years old of age, 55 years old mean age, the course of disease 2 months-8 months, average 4 months.Matched group male 66 example, women 50 example, oldest 74 years old, minimum 39 years old of age, 55 years old mean age, the course of disease 2 months-8 months, average 4 months.The relatively general clinical data of two groups of patients, difference has statistical significance (P > 0.05), can analyze contrast.Experimental group uses the present embodiment 5 products obtained therefrom, and every day twice, each 250mL(is warm).Matched group uses the medicine of conventional therapy esophageal carcinoma (as oxaliplatin fluorouracil, esophagus flat loose, anticancer pill ball, cinobufacin oral liquid etc.).Curative effect judging standard: cure: clinical symptoms all disappears, electronic gastroscopy and check pathological section result all normal; Effective: all or part of disappearance of clinical symptoms or electronic gastroscope show that cancerous protuberance has the change reduced; Invalid: clinical symptoms and inspection have no significant change.Total effectively comprising cures and effective.Treat after five months, result is as shown in table 1.
Table 1: embodiment 5 gained esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament decoction compliance test result [example (%)]
Therapeutic effect: cure 76 examples (65.52%), effective 38 examples (32.76%), invalid 2 examples (1.72%), total effective rate 98.28%.Successful is better than matched group.
The present invention selects Haematitum, Flos Caryophylli, Fructus Toosendan and Fructus Bruceae etc. to carry out compatibility, makes esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament.In side, Haematitum suppressing the hyperactive liver town is inverse, cooling blood for hemostasis.Flos Caryophylli warming middle-JIAO to send down the adverse QI, reinforcing the kidney and supporting YANG.Fructus Toosendan removes damp and hot, clearing away liver-fire, pain relieving, parasite killing.Fructus Bruceae heat clearing away, dampness, parasite killing, removing toxic substances.The detumescence of Nidus Vespae wind-expelling pain-stopping, rose poison, killing parasites for relieving itching.Chinese fanpalm seed blood circulation promoting and blood stasis dispelling, hard masses softening and resolving.Herba Centipedae is dispeled the wind, cold expelling, and victory is wet, removing nebula, stuffy nose relieving plug.Radix Phytolaccae leads to two just, removing water retention by purgation, eliminating stagnation.Herba Catharanthi Rosei detoxicating and fighting cancer, heat clearing away suppressing the hyperactive liver.Sal Ammoniacus removing food stagnancy softening the hard mass, drastically removing blood stasis and resolving static blood.Herba Hedyotidis Diffusae heat clearing away, dampness removing, removing toxic substances.Carnis Pseudosciaenae Air Bladder pseudosciaenae seu Acipenser has the kidney invigorating and essence nourishing, nourishes muscle arteries and veins, hemostasis, scattered silt, the effect of detumescence.All medicines share, and have blood circulation promoting and blood stasis dispelling, detoxicating and fighting cancer, heat clearing away suppressing the hyperactive liver, reducing swelling and alleviating pain, removing food stagnancy softening the hard mass, and the effect such as drastically removing blood stasis and resolving static blood, the kidney invigorating and essence nourishing, has good curative effect for esophageal carcinoma.
Finally it should be noted that, embodiment is the detailed description of the invention of optimum of the present invention, be not limited to the present invention, although with reference to previous embodiment to invention has been detailed description, for a person skilled in the art, it still can be modified to the technical scheme described in foregoing embodiments, or carries out equivalent replacement to wherein portion of techniques feature.Within the spirit and principles in the present invention all, any amendment done, equivalent replacement, improvement etc., all should be included within protection scope of the present invention.
Claims (10)
1. esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament, is characterized in that, takes off the primary raw material medicine stating weight proportion and is prepared from: Haematitum 6-10, Flos Caryophylli 10-15, Fructus Toosendan 15-20, Fructus Bruceae 9-18, Nidus Vespae 15-20, Chinese fanpalm seed 10-20, Herba Centipedae 15-30, Radix Phytolaccae 15-25, Herba Catharanthi Rosei 2-5, Sal Ammoniacus 2-5, Herba Hedyotidis Diffusae 9-15, Shishou Air Bladder pseudosciaenae seu Acipenser 6-15.
2. esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament according to claim 1, is characterized in that, takes off the primary raw material medicine stating weight proportion and is prepared from: Haematitum 7-9, Flos Caryophylli 11-13, Fructus Toosendan 17-19, Fructus Bruceae 12-15, Nidus Vespae 16-18, Chinese fanpalm seed 14-17, Herba Centipedae 20-25, Radix Phytolaccae 18-22, Herba Catharanthi Rosei 2.5-4, Sal Ammoniacus 2.5-4, Herba Hedyotidis Diffusae 11-13, Shishou Air Bladder pseudosciaenae seu Acipenser 8-13.
3. esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament according to claim 1, is characterized in that, takes off the primary raw material medicine stating weight proportion and is prepared from: Haematitum 8, Flos Caryophylli 12, Fructus Toosendan 18, Fructus Bruceae 13, Nidus Vespae 17, Chinese fanpalm seed 15, Herba Centipedae 22, Radix Phytolaccae 20, Herba Catharanthi Rosei 3, Sal Ammoniacus 3, Herba Hedyotidis Diffusae 12, Shishou Air Bladder pseudosciaenae seu Acipenser 10.
4., according to the arbitrary described esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament of claim 1-3, it is characterized in that, this esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament is made decoction, and the preparation method of described decoction is:
(1) wash Haematitum surface dirt with water, taking-up is dried, knock fritter, loads in crock, is placed in intense fire, burns to being popular in, and taking-up is placed on vinegar 2-5 two per jin in iron pan, and (preferred, taking-up is placed on vinegar 2.5-4 two per jin in iron pan; Be more preferably, take out and be placed on vinegar per jin 3 liang in iron pan), broken while hot, cool rear porphyrize, crosses 120-160 mesh sieve and (preferably, crosses 130-150 mesh sieve; Be more preferably, cross 140 mesh sieves);
(2) Sal Ammoniacus is picked decontamination, knock fritter, puts in boiling water and dissolves, and filters, removing residue, in impouring porcelain basin, with the evaporation of vinegar water proof, every 10 jin of Sal Ammoniacus vinegar 4-6 jin (preferred, every 10 jin of Sal Ammoniacus vinegar 4.5-5.5 jin; Be more preferably, every 10 jin of Sal Ammoniacus vinegar 5 jin), at any time the white that liquid level is separated out is floated frost and pull out, put in ceramic whiteware cylinder, dry, be ground into fine powder, cross 120-160 mesh sieve and (preferably, cross 130-150 mesh sieve; Be more preferably, cross 140 mesh sieves);
(3) Shishou Air Bladder pseudosciaenae seu Acipenser is cleaned, drain, explode to crisp with Oleum sesami, take out, be pressed into powder, cross 120-160 mesh sieve and (preferably, cross 130-150 mesh sieve; Be more preferably, cross 140 mesh sieves), put cold-bottling for subsequent use;
(4) by all the other the 7 taste crude drug removing impurity except Haematitum, Sal Ammoniacus, Shishou Air Bladder pseudosciaenae seu Acipenser, Flos Caryophylli and Herba Centipedae, clean, put into marmite, add water, amount of water is that doubly (preferred, amount of water is 6-7 times of 7 taste crude drug gross masses to the 5-8 of 7 taste crude drug gross masses; Be more preferably, amount of water is 6.5 times of 7 taste crude drug gross masses), first boil to boiling with big fire, rear turn of little fire decocts 1.1-2.1 hour, and (preferred, rear turn of little fire decocts 1.4-1.8 hour; Be more preferably, rear turn of little fire decocts 1.6 hours), leach medicinal liquid;
(5) Flos Caryophylli and Herba Centipedae being joined step (4) fills in the marmite of medicinal residues, adds water, and amount of water is that doubly (preferred, amount of water is 4-5 times of 9 taste medical material gross masses to the 3.5-6 of 9 taste medical material gross masses; Be more preferably, amount of water is 4.3 times of 9 taste crude drug gross masses), first boil to boiling with big fire, rear turn of little fire decocts 25-50 minute, and (preferred, rear turn of little fire decocts 30-45 minute; Be more preferably, rear turn of little fire decocts 38 minutes), leach medicinal liquid;
(6) step (4) and step (5) gained medicinal liquid are merged, then, step (1), step (2) and step (3) gained are added wherein, to obtain final product.
5., according to the arbitrary described esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament of claim 1-3, it is characterized in that, this esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament is made pill, and the preparation method of described pill is:
(1) wash Haematitum surface dirt with water, taking-up is dried, knock fritter, loads in crock, is placed in intense fire, burns to being popular in, and taking-up is placed on vinegar 2-5 two per jin in iron pan, and (preferred, taking-up is placed on vinegar 2.5-4 two per jin in iron pan; Be more preferably, take out and be placed on vinegar per jin 3 liang in iron pan), broken while hot, cool rear porphyrize, crosses 110-150 mesh sieve and (preferably, crosses 120-140 mesh sieve; Be more preferably, cross 130 mesh sieves);
(2) Sal Ammoniacus is picked decontamination, knock fritter, puts in boiling water and dissolves, and filters, removing residue, in impouring porcelain basin, with the evaporation of vinegar water proof, every 10 jin of Sal Ammoniacus vinegar 4-6 jin (preferred, every 10 jin of Sal Ammoniacus vinegar 4.5-5.5 jin; Be more preferably, every 10 jin of Sal Ammoniacus vinegar 5 jin), at any time the white that liquid level is separated out is floated frost and pull out, put in ceramic whiteware cylinder, dry, be ground into fine powder, cross 110-150 mesh sieve and (preferably, cross 120-140 mesh sieve; Be more preferably, cross 130 mesh sieves);
(3) Shishou Air Bladder pseudosciaenae seu Acipenser is cleaned, drain, explode to crisp with Oleum sesami, take out, be pressed into powder, cross 110-150 mesh sieve and (preferably, cross 120-140 mesh sieve; Be more preferably, cross 130 mesh sieves), put cold-bottling for subsequent use;
(4) all the other the 9 taste Chinese medicines except Haematitum, Sal Ammoniacus and Shishou Air Bladder pseudosciaenae seu Acipenser are removed impurity, porphyrize respectively, cross 110-150 mesh sieve and (preferably, cross 120-140 mesh sieve; Be more preferably, cross 130 mesh sieves);
(5) step (1), step (2), step (3) and step (4) gained fine powder are mixed, add water pill, heavy 0.25-0.7g(is preferred for every ball, the heavy 0.3-0.6g of every ball; Be more preferably, the heavy 0.5g of every ball), dry, to obtain final product.
6., according to the arbitrary described esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament of claim 1-3, it is characterized in that, this esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament is made powder, and the preparation method of described powder is:
(1) wash Haematitum surface dirt with water, taking-up is dried, knock fritter, loads in crock, is placed in intense fire, burns to being popular in, and taking-up is placed on vinegar 2-5 two per jin in iron pan, and (preferred, taking-up is placed on vinegar 2.5-4 two per jin in iron pan; Be more preferably, take out and be placed on vinegar per jin 3 liang in iron pan), broken while hot, cool rear porphyrize, crosses 130-170 mesh sieve and (preferably, crosses 140-160 mesh sieve; Be more preferably, cross 150 mesh sieves);
(2) Sal Ammoniacus is picked decontamination, knock fritter, puts in boiling water and dissolves, and filters, removing residue, in impouring porcelain basin, with the evaporation of vinegar water proof, every 10 jin of Sal Ammoniacus vinegar 4-6 jin (preferred, every 10 jin of Sal Ammoniacus vinegar 4.5-5.5 jin; Be more preferably, every 10 jin of Sal Ammoniacus vinegar 5 jin), at any time the white that liquid level is separated out is floated frost and pull out, put in ceramic whiteware cylinder, dry, be ground into fine powder, cross 130-170 mesh sieve and (preferably, cross 140-160 mesh sieve; Be more preferably, cross 150 mesh sieves);
(3) Shishou Air Bladder pseudosciaenae seu Acipenser is cleaned, drain, explode to crisp with Oleum sesami, take out, be pressed into powder, cross 130-170 mesh sieve and (preferably, cross 140-160 mesh sieve; Be more preferably, cross 150 mesh sieves), put cold-bottling for subsequent use;
(4) all the other the 9 taste Chinese medicines except Haematitum, Sal Ammoniacus and Shishou Air Bladder pseudosciaenae seu Acipenser are removed impurity, porphyrize respectively, cross 130-170 mesh sieve and (preferably, cross 140-160 mesh sieve; Be more preferably, cross 150 mesh sieves);
(5) step (1), step (2), step (3) and step (4) gained fine powder are mixed, sterile packaged, often wrap 4 grams.
7., according to the arbitrary described esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament of claim 1-3, it is characterized in that, this esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament is made thick paste agent, and the preparation method of described thick paste agent is:
(1) wash Haematitum surface dirt with water, taking-up is dried, knock fritter, loads in crock, being placed in intense fire, burning to being popular in, take out and be placed on vinegar 2-5 two per jin in iron pan, broken while hot, cool rear porphyrize, crosses 120-160 mesh sieve and (preferably, crosses 130-150 mesh sieve; Be more preferably, cross 140 mesh sieves);
(2) Sal Ammoniacus is picked decontamination, knock fritter, puts in boiling water and dissolves, filter, removing residue, in impouring porcelain basin, evaporate with vinegar water proof, every 10 jin of Sal Ammoniacus vinegar 4-6 jin, float frost by the white that liquid level is separated out at any time and pull out, put in ceramic whiteware cylinder, dry, be ground into fine powder, cross 120-160 mesh sieve and (preferably, cross 130-150 mesh sieve; Be more preferably, cross 140 mesh sieves);
(3) Shishou Air Bladder pseudosciaenae seu Acipenser is cleaned, drain, explode to crisp with Oleum sesami, take out, be pressed into powder, cross 120-160 mesh sieve and (preferably, cross 130-150 mesh sieve; Be more preferably, cross 140 mesh sieves), put cold-bottling for subsequent use;
(4) by all the other the 7 taste crude drug removing impurity except Haematitum, Sal Ammoniacus, Shishou Air Bladder pseudosciaenae seu Acipenser, Flos Caryophylli and Herba Centipedae, clean, put into marmite, add water, amount of water is that doubly (preferred, amount of water is 6-7.5 times of 7 taste crude drug gross masses to the 5.5-8.5 of 7 taste crude drug gross masses; Be more preferably, amount of water is 7 times of 7 taste crude drug gross masses), first boil to boiling with big fire, rear turn of little fire decocts 1.3-2.3 hour, and (preferred, rear turn of little fire decocts 1.6-2 hour; Be more preferably, rear turn of little fire decocts 1.8 hours), leach medicinal liquid;
(5) Flos Caryophylli and Herba Centipedae being joined step (4) fills in the marmite of medicinal residues, adds water, and amount of water is that doubly (preferred, amount of water is 4-5 times of 9 taste crude drug gross masses to the 3.5-6 of 9 taste crude drug gross masses; Be more preferably, amount of water is 4.3 times of 9 taste crude drug gross masses), first boil to boiling with big fire, rear turn of little fire decocts 30-50 minute, and (preferred, rear turn of little fire decocts 35-45 minute; Be more preferably, rear turn of little fire decocts 40 minutes), leach medicinal liquid;
(6) step (4) and step (5) gained medicinal liquid are merged, decompression, is concentrated into the thick paste that relative density is 1.32-1.42, then adds refined honey, and it is preferred that every 100kg thick paste adds refined honey 125-150kg(, and every 100kg thick paste adds refined honey 135-145kg; Be more preferably, every 100kg thick paste adds refined honey 140kg, then step (1), step (2) and step (3) gained fine powder is added and mix well, micro-refining, foam removal, seals and get final product in dress aseptic bottle.
8. the preparation method of esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament according to claim 7, is characterized in that, takes out and be placed on vinegar 2.5-4 two (preferably take out and be placed on vinegar per jin 3 liang in iron pan) per jin in iron pan in step (1).
9. the preparation method of esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament according to claim 7, is characterized in that, every 10 jin of Sal Ammoniacus vinegar 4.5-5.5 jin (preferably every 10 jin of Sal Ammoniacus vinegar 5 jin) in step (2).
10. the preparation method of esophageal carcinoma blood circulation promoting and blood stasis dispelling medicament according to claim 7, is characterized in that, is concentrated into the thick paste (being preferably concentrated into the thick paste that relative density is 1.37) that relative density is 1.35-1.39 in step (6).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410760909.7A CN104491263A (en) | 2014-12-13 | 2014-12-13 | Medicine capable of promoting blood circulation to remove blood stasis for esophagus cancer and preparation method of medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410760909.7A CN104491263A (en) | 2014-12-13 | 2014-12-13 | Medicine capable of promoting blood circulation to remove blood stasis for esophagus cancer and preparation method of medicine |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104491263A true CN104491263A (en) | 2015-04-08 |
Family
ID=52932777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410760909.7A Pending CN104491263A (en) | 2014-12-13 | 2014-12-13 | Medicine capable of promoting blood circulation to remove blood stasis for esophagus cancer and preparation method of medicine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104491263A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106214909A (en) * | 2016-08-22 | 2016-12-14 | 鄢海军 | A kind of Chinese medicine tea bag alleviating recovery esophageal carcinoma disease |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102366522A (en) * | 2011-10-27 | 2012-03-07 | 党学德 | Chinese medicine pill for treating esophageal cancer and process technology |
CN103446550A (en) * | 2013-09-27 | 2013-12-18 | 张锦晔 | Traditional Chinese medicine preparation for treating cancers |
CN103635199A (en) * | 2011-05-09 | 2014-03-12 | 佑华·彼得·盛 | Herbal composition for treating cancer |
-
2014
- 2014-12-13 CN CN201410760909.7A patent/CN104491263A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103635199A (en) * | 2011-05-09 | 2014-03-12 | 佑华·彼得·盛 | Herbal composition for treating cancer |
CN102366522A (en) * | 2011-10-27 | 2012-03-07 | 党学德 | Chinese medicine pill for treating esophageal cancer and process technology |
CN103446550A (en) * | 2013-09-27 | 2013-12-18 | 张锦晔 | Traditional Chinese medicine preparation for treating cancers |
Non-Patent Citations (2)
Title |
---|
叶乃赐等: "白花蛇舌草的治疗经验", 《福建医药杂志》 * |
谢海洲等: "漫话食道癌", 《陕西中医》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106214909A (en) * | 2016-08-22 | 2016-12-14 | 鄢海军 | A kind of Chinese medicine tea bag alleviating recovery esophageal carcinoma disease |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20110073717A (en) | A functional food and making method of thereof | |
CN105232911B (en) | A kind of Chinese medicine composition | |
CN103463297B (en) | A kind of Chinese medicine composition for the treatment of eczema scrotum and its production and use | |
CN1109554C (en) | Medicine for treating allergic purpura | |
CN105535495B (en) | A kind of Chinese medicine composition and preparation method of the element culturing fixed folder treatment cancer of the esophagus | |
CN110652552A (en) | Wound healing formula and preparation method | |
CN104888174A (en) | Medicinal preparation for treating deficiency cold of spleen and stomach type peptic ulcer and preparation method thereof | |
US6998141B2 (en) | Medication combination for hepatoma and pancreatic cancer and preparation protocol | |
CN110063977B (en) | Radix codonopsis and sea buckthorn composite electuary and application thereof | |
CN104491263A (en) | Medicine capable of promoting blood circulation to remove blood stasis for esophagus cancer and preparation method of medicine | |
CN105617268A (en) | Medicine for treating scale keratinization type beriberi | |
CN104971316A (en) | Composition for treating esophageal cancer and preparation method thereof | |
CN105435190A (en) | Traditional Chinese medicine composition for treating cold-heat jumble asthma and preparation method of traditional Chinese medicine composition | |
CN104258224A (en) | Schisandra chinensis oral solution for treating lung-and-kidney yin-deficiency type chronic bronchitis and preparation method thereof | |
CN104522493A (en) | Health porridge for treating coronary atherosclerosis and preparation method of health porridge | |
CN104435744A (en) | Traditional Chinese medicine thick paste for treating functional dyspepsia and preparation method of traditional Chinese medicine thick paste | |
CN109771567A (en) | A kind of formula of Chinese herbal medicine supporting vital QI and dispersing blood stasis toxin expelling tumour | |
CN104491264A (en) | Heat and toxic material clearing preparation for treating esophageal cancer and preparation method of heat and toxic material clearing preparation | |
TWI260226B (en) | Complex prescription of Chinese medicine for the treatment of extensive cancer | |
CN105125985A (en) | Chinese and western medicine compound preparation for treating senile chronic bronchitis and preparation method thereof | |
CN104398627A (en) | Esophagus cancer medicament with poison for combating poison and preparation method of esophagus cancer medicament | |
CN104474161A (en) | Blood stasis-removing powder for treating esophageal cancer and preparation method of blood stasis-removing powder | |
CN104474440A (en) | Pharmaceutical composition for treatment of nutritional anemia of piglets and preparation method thereof | |
CN104707030A (en) | Traditional Chinese medicine pills for treating esophageal cancer and preparation method thereof | |
CN104224881A (en) | Medicine for treating malignant tumor of digestive system, and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: The 830000 Xinjiang Midong District of Urumqi Miquan Road No. 790 Building No. 3 1-402 Applicant after: Li Fei Address before: 250014 Shandong city in Ji'nan Province, Lixia District, Dongguan Street No. 38 Applicant before: Li Fei |
|
COR | Change of bibliographic data | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150408 |
|
RJ01 | Rejection of invention patent application after publication |